Health Sciences
A new device for early diagnosis of degenerative eye disorders
TechTransfer
EPFL
Researchers at an EPFL lab have developed an ophthalmological device that can be used to diagnose some degenerative eye disorders long before the onset of the first symptoms. In early clinical trials, the prototype was shown to produce images with a sufficient degree of precision in just five seconds.
Fighting tumours with magnetic bacteria
Research
ETH Zurich
Researchers at ETH Zurich are planning to use magnetic bacteria to fight cancerous tumours. They have now found a way for these microorganisms to effectively cross blood vessel walls and subsequently colonise a tumour.
Femtech, taboo-breaking innovations
TechTransfer
EPFL
Femtech is a term used to describe technologies and applications that focus on women’s health. While this new market offers immense growth potential, taboos around sexuality, periods and menopause continue to hamper progress. Here, we take a deep dive into the latest developments — at EPFL and beyond.
Textile electrodes for medtech applications
TechTransfer
Empa
Nahtlos, an Empa spin-off, has received 1 million Swiss francs in a first round of financing from a network of business angels from Switzerland and Liechtenstein and from the Startfeld Foundation. With this funding, Nahtlos aims to drive the market entry of its newly developed textile-based electrode for medical applications.
Paul Scherrer Institute and Apollo Health Ventures Launch Focal Biosciences
TechTransfer
PSI
Newly established Focal Biosciences will focus on bringing together leading experts and scientific discoveries to harness cellular reprogramming in the fight against common age-related diseases.
How genetics influences our body weight beyond the genes
Research
ETH Zurich
It is not only classical genes that determine our predisposition to obesity. Researchers at ETH Zurich have now shown that microRNA molecules play a central role in the regulation of body weight.
Page 12 of 23